Chester County News and Community Website
Teleflex Incorporated (NYSE: TFX), headquartered in Wayne, PA, is a global provider of medical technologies designed to improve the health and quality of people’s lives, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care.
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced the enrollment of the first patient in the DUBSTENT DIABETES trial, a new clinical study designed to evaluate whether combining two …
Teleflex Launches Clinical Trial Testing Dual-Device Heart Procedure for Diabetic Patients Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) announced that its management team will present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025, at 3:20 …
Teleflex to Present at Morgan Stanley Global Healthcare Conference Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced the commercial launch of its Barrigel™ rectal spacer in Japan, marking a significant step in the company’s international expansion strategy. The …
Teleflex Launches Barrigel™ Rectal Spacer in Japan Following Regulatory Approval Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) reported second quarter results that exceeded expectations and raised its full-year 2025 guidance following the successful acquisition of BIOTRONIK’s Vascular Intervention business.
Teleflex Raises 2025 Outlook Following Strong Q2 and BIOTRONIK Acquisition Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) will host a conference call to discuss its Q2 financial results and provide an operational update at 8:00 a.m. ET on Thursday, July …
Teleflex to Announce Q2 2025 Results: Join the Live Call July 31 Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced the recent completion of its acquisition of substantially all of BIOTRONIK SE & Co. KG’s Vascular Intervention business. The €760 million …
Teleflex Completes Acquisition of BIOTRONIK’s Vascular Intervention Business Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has announced findings from a new multinational study demonstrating the efficacy of its Arrow™ Chlorhexidine-Impregnated Central Venous Catheters (CVCs) in reducing central line-associated …
Teleflex Study Shows 70.5% Reduction in CLABSI with Antimicrobial CVCs Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has introduced two major initiatives during Men’s Health Month to highlight the challenges men face with benign prostatic hyperplasia (BPH) and the importance …
Teleflex Launches Awareness Initiatives for Men’s Health Month Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has published its 2024 Global Impact Report, outlining the company’s significant achievements and ongoing commitment to Corporate Social Responsibility (CSR). The report highlights …
Teleflex Releases 2024 Global Impact Report, Showcasing CSR Progress Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) presented significant clinical findings at the 2025 American Urological Association (AUA) Annual Meeting in Las Vegas. The data from two randomized controlled trials …
Teleflex Highlights UroLift™ System’s Clinical Advantages at 2025 AUA Meeting Read More